Advances in Matrix Metalloproteinase Inhibitors Based on Pyrrolidine Scaffold

E-ISSN： 1875-533x|15|4|374-385

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.15, Iss.4, 2008-02, pp. : 374-385

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

CoMFA/CoMSIA and Molecular Docking Studies of Novel Matrix Metalloproteinase- 2 Inhibitors Based on L-tyrosine Scaffold

Letters in Drug Design & Discovery, Vol. 13, Iss. 5, 2016-06 ,pp. : 376-386

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Advances in Studies on Hydroxamates as Matrix Metalloproteinase Inhibitors: A Review

Current Medicinal Chemistry, Vol. 18, Iss. 11, 2011-04 ,pp. : 1704-1722

Bentham Science Publishers

Access to resources Recommend Favorite

Matrix metalloproteinase inhibitors

Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 10, 1997-10 ,pp. : 1213-1216

Informa Healthcare

Access to resources Recommend Favorite

Matrix metalloproteinase inhibitors and cancer

By Lauer-Fields J.L. Fields G.B.

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 12, 2000-12 ,pp. : 1873-1884

Informa Healthcare

Access to resources Recommend Favorite

Matrix metalloproteinase inhibitors 1998

By Beckett R.P. Whittaker M.

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 3, 1998-03 ,pp. : 259-282

Informa Healthcare

Access to resources Recommend Favorite